However, the value of exponent γ is lower when all data from the advancing and storage stages (method II) are used for calculation of the infiltration parameters.
Furthermore, the data from the advancing and storage stages (method II) are more appropriate for the calculation of infiltration parameters than the data from the advancing stage (method I), due to the fact that in method II, data were calculated from complete furrow irrigation including advancing and storage stages.
For the work described here, we used data from the controls advanced research turbine (CART) at the National Wind Technology Center NWTCC) at the National Renewable Energy Laboratory NRELL).
Mathematic models were derived to compute the transient infiltration rates with data from the advance process of runoff water on soil surface and depth of water ponded on the soil surface.
Similar analysis performed on the data from the ADVANCE study showed that severe hypoglycemia was associated with significant increase in risks of major macrovascular events (HR 2.88 [95% CI 2.01 4.12]), death from cardiovascular disease (2.68 [1.72–4.19]), and all-cause mortality (2.69 [1.97 3.67]); P < 0.001 for all comparisons) (27).
The study used data from the Mars Advanced Radar for Subsurface and Ionosphere Sounding, or MARSIS, aboard the European Space Agency's Mars Express Orbiter.
Summary data from the ACCORD, ADVANCE, VADT, RECORD, PROactive, ADOPT (A Diabetes Outcome Progression Trial), and BARI 2D studies were used for model development (Table 2).
Substantial data from the UK Prospective Diabetes Study UKPDSS), ADVANCE, and ACCORD support the hypothesis that, in general, those with type 2 diabetes who receive treatment to lower A1C levels may have lower rates of onset and progression of albuminuria a result that our data support (6, 7, 24).
These slides were then used to determine whether data from the run would advance into their data analysis pipeline by qualitatively scoring the run as 'Pass' or 'Fail'.
Here, we present a comprehensive comparison between the two aCGH platforms using available data from 19 human advanced prostate cancer (European PRIMA project, PRostate cancer Integral Management Approach) obtained at two independent sites with the same batch of DNA.
